Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer

Exclusion Criteria

• •Distant metastases as determined clinically or radiographically based upon standard-of-care work-up for endometrial cancer.
• •Concurrent (or other) chemotherapy occurring at the time of study.
• •Gross residual disease (cancer cells that remain after attempts to remove the cancer have been made) post-operatively and/or at the time of radiation based upon pre-op or post-op imaging, intra-operative findings, and gynecologic oncologists' judgment.
• •History of small bowel obstruction, inflammatory bowel disease, irritable bowel syndrome, connective tissue disorder requiring ongoing active medical management, or prior radiation therapy directed to the pelvis.
• •Unresolved grade 2 or higher chemotherapy-associated diarrhea or abdominopelvic pain requiring medication prior to the initiation of radiation.
• •Recommendation to undergo para-aortic nodal irradiation.